93772-89-5

Usage

Uses

Used in Pharmaceutical Industry:
(+/-)-methyl 2-(2,3-dihydro-5-methoxybenzofuran-3-yl)acetate is used as an intermediate in the synthesis of pharmaceutical compounds for its potential therapeutic properties.
Used in Drug Development Research:
(+/-)-methyl 2-(2,3-dihydro-5-methoxybenzofuran-3-yl)acetate is used as a research compound for the development of new drugs and treatments due to its potential therapeutic properties.
Used as an Antioxidant:
(+/-)-methyl 2-(2,3-dihydro-5-methoxybenzofuran-3-yl)acetate is used as an antioxidant in various applications, such as in the food and cosmetic industries, to prevent oxidation and extend shelf life.

Upstream product

• 70775-39-2 dimethylsulfoxonium methylide 
• 93198-67-5 methyl (E)-3-(2-hydroxy-5-methoxyphenyl)acrylate 
• 118610-60-9 methyl 2-(5-methoxybenzofuran-3-yl)acetate 
• 17918-14-8 2,5-dimethoxybenzoyl chloride 
• 2785-98-0 2,5-dimethoxybenzoic acid 
• 39581-55-0 5-methoxy-benzofuran-3-one 
• 150-76-5 4-methoxy-phenol 
• 17332-11-5 2-bromo-4-methoxyphenol 
• 589090-73-3 methyl 4-(2-bromo-4-methoxyphenoxy)but-2-enoate 

Downstream Products

• 589091-16-7 (+/-)-2-(5-methoxy-2,3-dihydrobenzofuran-3-yl)ethyl p-toluenesulfonate 

Relevant academic research and scientific papers

Electron Impact Mass Spectrometry of Some 2,3-Dihydro-1-benzofuran-3-acetic Acids

The mass spectrometric behaviour of four 2,3-dihydro-1-benzofuran-3-acetic acids has been studied in detail with the aid of exact mass measurements, linked scans, collisionally activated decomposition, mass analysed ion kinetic energy spectra and labelling experiments.Unusual fragmentation pathways are emphasized for which mechanisms are proposed.

Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT2A/2C receptor ligands

In studies of the SAR of phenethylamine-type serotonin 5-HT2A receptor agonists, substituted conformationally constrained tetrahydronaphthofurans were designed to investigate the optimal conformation of the 2-aminoethyl moiety. These compounds

Substituted naphthofurans as hallucinogenic phenethylamine -Ergoline hybrid molecules with unexpected muscarinic antagonist activity

A series of substituted racemic naphthofurans were synthesized as 'hybrid' molecules of the two major prototypical hallucinogenic drug classes, the phenethylamines and the tryptamines/ergolines. Although it was hypothesized that these new agents might pos

CNS affecting 5-oxy-3-aminomethyl-dihydro-benzofurans and benzothiophenes

The present invention relates to 3-aminomethyl derivatives of indane, dihydrobenzofurane, dihydrobenzothiophene, and indoline, acid addition salts thereof, isomers thereof, methods of preparation, pharmaceutical compositions and method of treating CNS-disorders such as schizophrenia, Parkinson's disease, depression, anxiety, migraine and senile dementia, or in the cure of cardiovascular diseases, by administering such a derivative.

OXYGEN HETEROCYCLES BY SULPHUR YLIDE ANNULATION: 2,3-DIHYDRO-BENZOFURAN-3-ACETIC ACIDS FROM ortho-HYDROXYBENZALACETIC ACID METHYL ESTERS AND DIMETHYLSULPHOXONIUM METHYLIDE

Several 2,3-dihydro-benzofuran-3-acetic acids have been synthesized from ortho-hydroxybenzalacetic acid methyl esters and dimethylsulphoxonium methylide by an annulation reaction.